Behavioral Health Technology

Abbott's deep brain stimulation device was awarded the FDA's breakthrough device designation for treatment-resistant depression, Abbott said July 27. 

Smitta Patel, MD, a psychiatrist at the UCLA Semel Institute for Neuroscience and Human Behavior, is joining VyTrac Health's medical advisory board. 

Medical technology company Neuronetics will be the exclusive supplier of transcranial magnetic stimulation equipment used in the mental health treatment network of Arkansas-based Alleviant Health, Neuronetics said July 25.

In clinical trials, four in-development psychiatric drugs show promise for treatment of schizophrenia, postpartum depression and major depressive disorder, MDLinx reported July 21.

The FDA has approved Neuronetics' transcranial magnetic stimulation system as a treatment for adults with major depressive disorder, the company said this week.

Wysa, an artificial intelligence digital mental health platform, nabbed $20 million in funding, the company said July 18.

Below are Forbes' top five virtual psychiatry platforms, determined considering costs, conditions treated, quality of providers and more, published July 14.

The U.S. has seen a broad push for increased mental health resources since the beginning of the COVID-19 pandemic, but staffing and provider counts are still woefully inadequate in some places.

Nevada HHS is using a $3.8 million grant to launch Virtual Crisis Care, a program providing law enforcement with 24/7 access to counselors when responding to mental health crisis calls, law enforcement news source Police1 reported July 7.

Arise, a mental healthcare company aiming to provide comprehensive virtual care for eating disorders, launched July 11 after raising over $4 million in a seed-funding round.